← Leaderboards
Douglas E. Brough
Genvec, Inc.
$697,273
Attributed
$697,273
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $335.1K · FY2005–17$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$912,358 · 5
By mechanism
R41$473,659 · 3
R43$438,699 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyCellsGene TherapyAdenovirusesBaseGene DeliveryGene ExpressionGenesLeadVectorSerotypingIn VivoGenerationsAdenovirus VectorDefectCrispr/Cas TechnologyBlood VesselsCochlear StructureEventCmv PromoterBedsEquilibriumEpitheliumClinic
Grant awards (5)
In Vivo Editing for Hemophilia Gene Therapy$215,085
R41 · FY2017 · TR · contact PI
ConProject-001$119,999
R41 · FY2017 · TR · contact PI
Pre-erythrocytic Stage Antigen Discovery for Malaria Vaccine Development$300,000
R43 · FY2013 · AI · contact PI
Development of Novel Alternative Serotype Adenoviral Vectors for Gene Delivery in$138,699
R43 · FY2009 · DC · contact PI
Restoration of vestibular hair cells induced by AdMath1$138,575
R41 · FY2005 · DC